Advise Limiting NSAIDs in Patients With Cardiovascular Disease

September 2015

You'll see even stronger CV warnings for Rx and OTC NSAIDs.

For example, labels will clarify that NSAIDs slightly increase CV risk in patients with OR without CV disease. They'll also say risk goes up within DAYS of use...and with higher NSAID doses and longer durations.

A big study will shed light on NSAID risks...but not until 2016.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Don't Automatically Give the Live Intranasal Vaccine to Kids
NSAIDs Advise Limiting NSAIDs in Patients With Cardiovascular Disease
Cardiology Don't Routinely Recommend Praluent for High Cholesterol
Cardiology Save Entresto for Persistent Heart Failure Symptoms
Lice Advise Reapplying Nix in 7 to 10 Days Even if Labels Say Otherwise
Pharmacogenetics Be Aware of Situations Where Pharmacogenetic Testing Makes Sense
Gastroenterology Explain That Any Risk of Heart Attack With PPIs Is Very Small
Infectious Diseases Dispel the Myth That Discolored Nasal Mucus Always Means a Bacterial Infection
Antipsychotics Check Patients Get At Least 4 Months of Invega Sustenna BEFORE Invega Trinza
Stroke Don't Suggest Jumping to Clopidogrel if Patients Have a GI Bleed on Aspirin
Otics Consider Alternatives for A/Band Unapproved Otics
Practice Be ready when DEA brings back National Rx Drug Take-Back Day
Sleep Disorders Don't Recommend Hetlioz for Most Insomnia Patients

Advise Limiting NSAIDs in Patients With Cardiovascular Disease

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents